AngioDynamics Inc (ANGO)
6.825
+0.14
(+2.17%)
USD |
NASDAQ |
Nov 04, 13:14
AngioDynamics Revenue (Quarterly): 67.49M for Aug. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 67.49M |
| May 31, 2024 | 70.98M |
| February 29, 2024 | 75.18M |
| November 30, 2023 | 79.07M |
| August 31, 2023 | 78.68M |
| May 31, 2023 | 91.07M |
| February 28, 2023 | 80.71M |
| November 30, 2022 | 85.43M |
| August 31, 2022 | 81.54M |
| May 31, 2022 | 87.00M |
| February 28, 2022 | 73.97M |
| November 30, 2021 | 78.28M |
| August 31, 2021 | 76.97M |
| May 31, 2021 | 76.84M |
| February 28, 2021 | 71.18M |
| November 30, 2020 | 72.77M |
| August 31, 2020 | 70.22M |
| May 31, 2020 | 58.33M |
| February 29, 2020 | 69.78M |
| November 30, 2019 | 70.00M |
| August 31, 2019 | 66.04M |
| May 31, 2019 | 71.18M |
| February 28, 2019 | 65.52M |
| November 30, 2018 | 69.98M |
| August 31, 2018 | 63.94M |
| Date | Value |
|---|---|
| May 31, 2018 | 5.687M |
| February 28, 2018 | 83.85M |
| November 30, 2017 | 86.71M |
| August 31, 2017 | 85.41M |
| May 31, 2017 | 7.059M |
| February 28, 2017 | 85.60M |
| November 30, 2016 | 89.03M |
| August 31, 2016 | 88.10M |
| May 31, 2016 | 93.42M |
| February 29, 2016 | 87.43M |
| November 30, 2015 | 89.28M |
| August 31, 2015 | 83.75M |
| May 31, 2015 | 90.46M |
| February 28, 2015 | 86.60M |
| November 30, 2014 | 92.15M |
| August 31, 2014 | 87.33M |
| May 31, 2014 | 94.06M |
| February 28, 2014 | 88.15M |
| November 30, 2013 | 88.57M |
| August 31, 2013 | 83.64M |
| May 31, 2013 | 89.92M |
| February 28, 2013 | 81.57M |
| November 30, 2012 | 87.01M |
| August 31, 2012 | 83.41M |
| May 31, 2012 | 57.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
58.33M
Minimum
May 2020
91.07M
Maximum
May 2023
75.78M
Average
76.01M
Median
Revenue (Quarterly) Benchmarks
| Accuray Inc | 134.29M |
| Masimo Corp | 496.30M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.80M |
| Total Expenses (Quarterly) | 76.20M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 221.24M |
| Gross Profit Margin (Quarterly) | 54.41% |
| Profit Margin (Quarterly) | -18.96% |
| Earnings Yield | -88.35% |
| Normalized Earnings Yield | -17.82 |